z-logo
open-access-imgOpen Access
Phosphorous Dysregulation Induced by MEK Small Molecule Inhibitors in the Rat Involves Blockade of FGF-23 Signaling in the Kidney
Author(s) -
Dolores Diaz,
Krishna P. Allamneni,
Jacqueline M. Tarrant,
Sock-Cheng Lewin-Koh,
Rama Pai,
Preeti Dhawan,
Gary Cain,
Cleopatra Kozlowski,
Hajime Hiraragi,
Nghi La,
Dylan P. Hartley,
Xiao Ding,
B.J. Dean,
Sheila Bheddah,
Donna M. Dambach
Publication year - 2011
Publication title -
toxicological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.352
H-Index - 183
eISSN - 1096-6080
pISSN - 1096-0929
DOI - 10.1093/toxsci/kfr263
Subject(s) - blockade , fibroblast growth factor , small molecule , kidney , chemistry , signal transduction , cancer research , microbiology and biotechnology , pharmacology , medicine , endocrinology , biology , biochemistry , receptor
MEK, a kinase downstream of Ras and Raf oncogenes, constitutes a high priority target in oncology research. MEK small molecule inhibitors cause soft tissue mineralization in rats secondary to serum inorganic phosphorus (iP) elevation, but the molecular mechanism for this toxicity remains undetermined. We performed investigative studies with structurally distinct MEK inhibitors GEN-A and PD325901 (PD-901) in Sprague-Dawley rats. Our data support a mechanism that involves FGF-23 signal blockade in the rat kidney, causing transcriptional upregulation of 25-hydroxyvitamin D(3) 1-alpha-hydroxylase (Cyp27b1), the rate-limiting enzyme in vitamin D activation, and downregulation of 1,25-dihydroxyvitamin D(3) 24-hydroxylase (Cyp24a1), the enzyme that initiates the degradation of the active form of vitamin D. These transcriptional changes increase serum vitamin D levels, which in turn drive the increase in serum iP, leading to soft tissue mineralization in the rat.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom